Call Us Now: +353 41 214 5111

Treatment Programme for Sex Addiction

Sex Addiction treatment: Symptoms, Treatment, and Outlook

Sexual compulsivity is a behavioural addiction whereby the sufferer has a compulsion to engage excessively in sexual activities and view pornography to a degree that creates a significantly negative impact on their life.

Sex addiction can lead to relationship problems, friendship problems, difficulties at work, substance abuse, depression and sometimes suicide.

Behavioural addictions often develop alongside alcohol and drug addictions. A dual diagnosis of alcohol or drug addiction and sexual compulsivity is best treated in a residential rehab centre. This means both disorders can be treated at the same time with the support of an attentive team of medical experts.  

Treatment for Sex and Pornography Addiction

At Smarmore Castle, we treat people suffering from sex and pornography addictions, alongside a primary diagnosis of alcohol or drug addiction. See more on our dual diagnosis programme.

Our treatment programme is founded on the 12 steps model and combines Cognitive Behavioural Therapy (CBT)Trauma Therapy and Attachment Theory work to treat the psychological issues contributing to sex addiction.

We help you to:

  • Learn about your sex addiction and underlying psychological issues,
  • Change negative thought processes around sex, love and relationships,
  • Work on trauma issues,
  • Improve your self-esteem, confidence and impulse control,
  • Repair damaged relationships with those close to you.

Self-Help Groups for Sex Addiction, Ireland

If you are concerned that you may be developing compulsive sexual behaviour then you can attend your local Sex and Love Addicts Anonymous group.

Help for Sex Addiction

If you or someone close to you is suffering from a sex or pornography addiction, contact us for professional advice. We are available to answer queries 24 hours a day, 7 days a week, and can arrange a quick admission.

Related pages

Smarmore Castle Brochure.pdf

Last updated on clinically assessed 26 August, 2021